iOrganBio is a pioneering cell production platform.
iOrganBio has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in October 2025.
iOrganBio's investors include SOSV, First Star Ventures, SOSV SF & NY (Fka IndieBio), Cape Fear BioCapital, Terasaki Institute.
iOrganBio is headquartered in Chapel Hill, United States.
iOrganBio is a pioneering cell production platform.
iOrganBio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"iOrganBio — Funding & Investors." VCBacked, October 29, 2025, https://www.vcbacked.co/company/iorganbio. Accessed September 2, 2026.
VCBacked. (2025). iOrganBio — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/iorganbio
{{cite web |title=iOrganBio — Funding & Investors |url=https://www.vcbacked.co/company/iorganbio |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated